GuidelineJournal of Korean medical science2010
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.
Guideline in Journal of Korean medical science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.Journal of Korean medical science · 2010Guideline
- Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.Investigational new drugs · 2012Trial
- Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification.Journal of gastric cancer · 2026Review
- Review
- Variation in mitotic counting and risk classification practices for gastrointestinal stromal tumors: a survey of pathologists in South Korea.Journal of pathology and translational medicine · 2025Article
- Giant gastric GIST with fast-growing mass after intra-tumoral bleeding.Journal of surgical case reports · 2023Article
- Artificial Intelligence in the Pathology of Gastric Cancer.Journal of gastric cancer · 2023Review
- Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms.Journal of pathology and translational medicine · 2021Review
- Laparoscopic Local Resection through Subserosal Dissection with Endoscopic Air-Insufflation for Submucosal Tumors Located Near the Esophagogastric Junction.Journal of minimally invasive surgery · 2020Article
- Long-Term Outcomes after Endoscopic Treatment of Gastric Gastrointestinal Stromal Tumor.Clinical endoscopy · 2016Review
- Endoscopic and Laparoscopic Full-Thickness Resection of Endophytic Gastric Submucosal Tumors Very Close to the Esophagogastric Junction.Journal of gastric cancer · 2015Article
- Application of blunt dissection in ESD of a gastric submucosal tumor.World journal of gastroenterology · 2014Article
- Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor.Journal of Korean medical science · 2013Article
- Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.Cancer research and treatment · 2012Article
- Clinicopathologic change of gastrointestinal stromal tumor after neoadjuvant imatinib followed by surgical resection.Journal of the Korean Surgical Society · 2012Article
- Response to imatinib rechallenge in a patient with a recurrent gastrointestinal stromal tumor after adjuvant therapy: a case report.Journal of medical case reports · 2011Article
- Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor.Journal of the Korean Society of Coloproctology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the rarity in incidence and prevalence, gastrointestinal stromal tumor (GIST) has emerged as a distinct pathogenetic entity. And the clinical management of GIST has been evolving very rapidly due to the recent recognition of its oncogenic signal transduction pathway and the introduction of new molecular-targeted therapy. Successful management of GIST requires a multidisciplinary approach firmly based on accurate histopathologic diagnosis. However, there was no standardized guideline for the management of Korean GIST patients. In 2007, the Korean GIST study group (KGSG) published the first guideline for optimal diagnosis and treatment of GIST in Korea. As the second version of the guideline, we herein have updated recent clinical recommendations and reflected changes in diagnosis, surgical and medical treatments for more optimal clinical practice for GIST in Korea. We hope the guideline can be of help in enhancing the quality of diagnosis by members of the Korean associate of physicians involving in GIST patients's care and subsequently in achieving optimal efficacy of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.